Methods of treating vascular inflammatory pathology using anti-TNF antibodies and fragments thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 7744885
APP PUB NO 20090022718A1
SERIAL NO

12001071

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Anti-TNF antibodies, fragments and regions thereof which are specific for human tumor necrosis factor-α (TNFα) and are useful in vivo diagnosis and therapy of a number of TNFα-mediated pathologies and conditions, as well as polynucleotides coding for murine and chimeric antibodies, methods of producing the antibody, methods of use of the anti-TNF antibody, or fragment, region or derivative thereof, in immunoassays and immunotherapeutic approaches are provided.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddressTotal Patents
CENTOCOR, INC.MALVERN, PA72
NEW YORK UNIVERSITYNEW YORK, NY929

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Daddona, Peter Menlo Park, US 59 1430
Ghrayeb, John Thorndale, US 68 2291
Knight, David Berwyn, US 116 2535
Le, Junming Jackson Heights, US 59 2159
Siegel, Scott Westborough, US 44 1284
Vilcek, Jan New York, US 54 1794

Cited Art Landscape

Patent Info (Count) # Cites Year
 
Other [Check patent profile for assignment information] (3)
6419927 Method for reducing adverse effects of a human 70kDa mediator which results from endotoxin stimulation of macrophages 41 1994
2007/0196,373 Anti-TNF antibodies and peptides of human tumor necrosis factor 99 2006
2008/0025,976 Methods of treating ankylosing spondylitis using anti-TNF antibodies and peptides of human tumor necrosis factor 105 2007
 
L'OREAL (1)
5993833 Histamine antagonist, an interleukin-1 antagonist and/or a TNF alpha antagonist in a cosmetic, pharmaceutical or dermatological composition 50 1997
 
PEPTIDE TECHNOLOGY LTD. (1)
5959087 Tumour necrosis factor binding ligands 52 1997
 
ABBVIE DEUTSCHLAND GMBH & CO. KG (1)
6914128 Human antibodies that bind human IL-12 and methods for producing 169 2000
 
FARMITALIA CARLO ERBA S.R.L. (1)
5436154 Monoclonal antibodies against human Tumor Necrosis Factor .alpha. 60 1991
 
TEIJIN LIMITED (1)
5075236 Method of detecting Kawasaki disease using anti-tumor necrosis antibody 54 1988
 
CELLTECH R&D LIMITED (1)
5994510 Recombinant antibodies specific for TNF.alpha. 132 1995
 
ROCKERFELLER UNIVERSITY, A CORP. OF N.Y. (1)
4603106 Lipoprotein lipase suppression by endotoxin-induced mediator (shock assay) 93 1982
 
SCHERING AKTIENGESELLSCHAFT (1)
5506265 Prostacyclin and carbacyclin derivatives as agents for the treatment of multiple sclerosis 18 1994
 
BAYER HEALTHCARE LLC (1)
5654407 Human anti-TNF antibodies 174 1995
 
DANA-FARBER CANCER INSTITUTE, INC. (2)
5730975 Treatment of insulin resistance in obesity linked type II diabetes using antagonist to TNF-alpha function 59 1994
6015558 Treatment of insulin resistance in obesity linked type II diabetes using antagonists to TNF-.alpha. function 55 1998
 
PHARMACIA S.P.A. (1)
6172202 Synthesis of polymer bio-active conjugates 44 1997
 
Hoechst Aktiengesellschaft (1)
5958413 Use of antibodies to TNF or fragments derived thereof and xanthine derivatives for combination therapy and compositions therefor 76 1997
 
The Mathilda and Terence Kennedy Institute of Rheumatology Trust (1)
5741488 Treatment of rheumatoid arthritis with anti-CD4 antibodies in conjunction with anti-TNF antibodies 77 1995
 
Otsuka Pharmaceutical Co., Ltd. (1)
5360716 Human tumor necrosis factor .alpha.specific monoclonal antibody and method for detecting human tumor necrosis factor .alpha. 53 1993
 
ADOLOR CORPORATION (1)
6190691 Methods for treating inflammatory conditions 141 1998
 
GENENTECH, INC. (1)
4816567 Recombinant immunoglobin preparations 2289 1983
 
HEALTH RESEARCH, INC. (1)
5342613 Pharmaceutical compositions and use thereof in the treatment of psoriasis 42 1992
 
BIOGEN, INC. (1)
5750105 Recombinant antibodies for human therapy 106 1995
 
PHARMACIA & UPJOHN S.P.A. (2)
5700788 Ureido derivatives of naphthalenephosphonic acids 38 1995
6194451 Matrix metalloproteinase inhibitors 40 1999
 
Advanced Biotherapy Concepts, Inc. (1)
5888511 Treatment of autoimmune diseases, including AIDS 161 1996
 
BRISTOL-MYERS SQUIBB PHARMA COMPANY (1)
5874441 Carbocyclic and hetertocyclic fused-ring quinolinecarboxylic acids useful as immunosuppressive agents 10 1997
 
BIOGEN IDEC INC. (1)
5658570 Recombinant antibodies for human therapy 171 1995
 
CDP HOLDINGS CORP. (FORMERLY GEKKO HOLDINGS CORP) (1)
5223395 Immunometric assays for tumor necrosis factor-alpha and methods for preventing the loss of biological activity of tumor necrosis factor-alpha in biological samples 56 1988
 
ABBVIE BIOTECHNOLOGY LTD (1)
6090382 Human antibodies that bind human TNF.alpha. 274 1996
 
BASF AKTIENGESELLSCHAFT (1)
5231024 Monoclonal antibodies against human tumor necrosis factor (TNF), and use thereof 208 1987
 
NEW YORK UNIVERSITY (45)
5656272 Methods of treating TNF-.alpha.-mediated Crohn's disease using chimeric anti-TNF antibodies 245 1994
5919452 Methods of treating TNF.alpha.-mediated disease using chimeric anti-TNF antibodies 106 1994
6284471 Anti-TNFa antibodies and assays employing anti-TNFa antibodies 80 1994
5698195 Methods of treating rheumatoid arthritis using chimeric anti-TNF antibodies 153 1994
6277969 Anti-TNF antibodies and peptides of human tumor necrosis factor 95 1998
6790444 Anti-TNF antibodies and peptides of human necrosis factor 37 2001
6835823 Anti-TNF antibodies and peptides of human tumor necrosis factor 40 2001
6991791 Anti-TNF antibodies and peptides of human tumor necrosis factor 42 2001
7101674 Anti-idiotypic anti-TNF antibodies and related immunoassay methods 20 2001
7192584 Methods of treating psoriasis with anti-TNF antibodies 94 2001
7214376 Methods of inhibiting TNF.alpha. in patients with neoplastic disease 13 2001
7169386 Methods of treating inflammation associated with viral infection with anti-TNF antibodies 13 2002
7226593 Methods of treating cachexia with chimeric anti-TNF antibodies 15 2002
2002/0146,419 Methods of treating ankylosis with chimeric anti-TNF antibodies 14 2002
7135178 Methods of treating disseminated intravascular coagulation using anti-TNF antibodies 14 2002
7179466 Methods of treating rheumatoid arthritis by multiple administration of anti-TNF antibodies 14 2002
7070775 Recombinant A2-specific TNF.alpha. specific antibodies 151 2002
7160995 DNA encoding anti-TNF antibodies and peptides 13 2002
2003/0147,891 Anti-TNF antibodies and peptides of human tumor necrosis factor 19 2002
7223396 Methods of treatment of fistulas in Crohn's disease with anti-TNF antibodies 12 2002
7166284 Methods of treating joint inflammation with anti-TNF antibodies 14 2003
7204985 Methods of treating disseminated intravascular coagulation by multiple administration of anti-TNF antibodies 12 2003
7128907 Methods of treating crohn's disease with anti-TNF antibodies 15 2003
2004/0115,200 Methods of treating neurodegenerative inflammation with chimeric anti-TNF antibodies 14 2003
7252823 Recombinant A2-specific TNF.alpha.-specific antibodies 11 2004
7169388 Methods of inhibiting TNF.alpha. in patients with cancer 13 2004
2005/0074,454 Methods of treating carcinoma using anti-TNF antibodies and peptides 8 2004
2005/0249,735 Methods of treating ankylosing spondylitis using anti-TNF antibodies and peptides of human tumor necrosis factor 113 2004
2005/0255,104 Methods of treating psoriasis using anti-TNF receptor fusion proteins 14 2005
2005/0260,201 Methods of treating rheumatoid arthritis using anti-TNF receptor fusion proteins 17 2005
7227003 Anti-TNF antibody fragments 14 2005
7160542 Method of treating psoriasis using human anti-TNF antibodies and fragments 13 2005
7128908 Methods for treating systemic lupus erythematosus using anti-TNF antibodies and fragments thereof 14 2005
7135179 Methods for treating sarcoidosis using anti-TNF antibodies and fragments thereof 14 2005
2006/0018,907 Anti-TNF antibodies and peptides of human tumor necrosis factor 106 2005
* 7404955 Methods of inhibiting or neutralizing TNF.alpha. in patients with tissue injury 7 2005
7138118 Methods of treating rheumatoid arthritis with anti-TNF antibodies 26 2005
7160543 Methods of inhibiting TNF-.alpha. in patients with Crohn's disease 13 2005
7276239 Recombinant A2-specific TNF.alpha.-specific antibodies 120 2005
7179893 Recombinant anti-TNF-.alpha. antibodies 35 2006
2007/0298,040 Methods of treating seronegative arthropathy with anti-TNF antibodies 105 2006
7425330 Methods of inhibiting TNF.alpha. activity in the blood of a patient 6 2006
7335358 Methods of treating psoriasis with anti-TNF antibodies 9 2006
7416729 Methods of treating rheumatoid arthritis with anti-TNF antibodies 8 2007
7374761 Recombinant A2-specific TNF.alpha.-specific antibodies 6 2007
 
PHARMACIA AB (FORMERLY PHARMACIA & UPJOHN AB) (1)
5776947 Use of quinoline-3-carboxamide compounds for inhibiting the production of tumor necrosis factor (TNF) and/or for the treatment of septic shock 38 1996
 
The Rockefeller University (2)
4822776 Lipoprotein lipase suppression by endotoxin-induced mediator (shock assay) 63 1985
6309640 Lipoprotein lipase suppression by endotoxin-induced mediator (shock assay) 42 1995
* Cited By Examiner

Patent Citation Ranking

Forward Cite Landscape

Patent Info (Count) # Cites Year
 
INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (2)
* 8691226 Humanized anti-human tumor necrosis factor alpha monoclonal antibody and sequence thereof 0 2010
* 2012/0100,132 HUMANIZED ANTI-HUMAN TUMOR NECROSIS FACTOR ALPHA MONOCLONAL ANTIBODY AND SEQUENCE THEREOF 0 2010
* Cited By Examiner

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Dec 29, 2017
11.5 Year Payment $7400.00 $3700.00 $1850.00 Dec 29, 2021
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00